NJ State Employees Deferred Compensation Plan’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,000
| Closed | -$243K | – | 475 |
|
|
2024
Q2 | $243K | Buy |
+1,000
| New | +$243K | 0.03% | 397 |
|
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$200K | – | 488 |
|
|
2023
Q1 | $200K | Hold |
1,000
| – | – | 0.03% | 439 |
|
|
2022
Q4 | $238K | Hold |
1,000
| – | – | 0.04% | 400 |
|
|
2022
Q3 | $200K | Buy |
+1,000
| New | +$200K | 0.03% | 416 |
|